Home Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
Article
Licensed
Unlicensed Requires Authentication

Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted

  • Ahmet Uçar EMAIL logo , Nurçin Saka , Firdevs Baş , Mine Sukur , Sukran Poyrazoğlu , Feyza Darendeliler and Ruveyde Bundak
Published/Copyright: June 8, 2013

Abstract

Aims: To assess the frequency and severity of diabetic ketoacidosis (DKA) at disease onset in children newly diagnosed with autoimmune type 1 diabetes (T1D) in Istanbul in the last decade. Also, to evaluate the potential contribution of the national diabetes awareness programme (NDAP) initiated in 2010.

Methods: Four hundred and one consecutive children (mean±standard deviation, age 8.1±4.1 years) with a diagnosis of autoimmune T1D were evaluated retrospectively with respect to demographic, clinical, and laboratory data in relation to DKA at disease onset. The possible impact of NDAP on the rate of DKA at disease onset in the last 2 years was also evaluated by comparing the data related to the time intervals before and after the onset of the programme. The results were evaluated at 95% confidence interval and significance was granted for p≤0.05.

Results: The overall frequency of DKA at disease onset was 44.2%, with a significant trend for decline in rate of DKA at disease onset in the last decade (p=0.0001). There were no significant differences in proportions of newly diagnosed T1D patients with severe or moderate DKA over time. Mean body mass index standard deviation score tended to increase in the last decade, but not significantly (p=0.09). When the time intervals before and after the onset of NDAP were evaluated, there was a more than two-fold decrease in rate of DKA (from 49.3% to 23.9%) (p<0.0001).

Conclusions: The frequency of a DKA event at onset of T1D is still high in Istanbul children despite a decreasing trend in the last decade. NDAP may significantly contribute to the reduction in rate of DKA.


Corresponding author: Ahmet Uçar, PhD, Istanbul Medical Faculty, Paediatric Endocrinology and Diabetes Unit, Istanbul University, Çapa, Istanbul, Turkey, Phone: +90-2124142000-31645, Fax: +90-2125338333, E-mail: ;

References

1. Wolsdorf J, Craig ME, Daneman D, Dunger D, Edge J, et al. ISPAD clinical practice guidelines compendium. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes 2009;10:118–23.10.1111/j.1399-5448.2009.00569.xSearch in Google Scholar

2. Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in Northern Finland. Temporal changes over 20 years. Diabetes Care 2007;30:861–6.10.2337/dc06-2281Search in Google Scholar

3. Abdul-Rasoul M, Al-Mahdi M, Al-Qattan H, Al-Tarkatit N, Alkhouly M, et al. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics. Pediatr Diabetes 2010;11:351–6.10.1111/j.1399-5448.2009.00600.xSearch in Google Scholar

4. Neu A, Hofer ES, Karges B, Oeverink R, Rosenbauer J, et al. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care 2009;32:1647–8.10.2337/dc09-0553Search in Google Scholar

5. Bui TP, Werther GA, Cameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: a 15-yr experience. Pediatr Diabetes 2002;3:82–8.10.1034/j.1399-5448.2002.30204.xSearch in Google Scholar

6. Schober E, Waldhoer T, Rami B, Hofer S, Austrian Diabetes Incidence Study Group. Incidence and time trend of type 1 and type 2 diabetes in Austrian children 1999–2007. J Pediatr 2009;155:190–3.e1.10.1016/j.jpeds.2009.03.010Search in Google Scholar

7. Lévy-Marchal C, Patterson CC, Green A, EURODIAB ACE Study Group. Geographical variation of presentation at diagnosis of type 1 diabetes in children: the EURODIAB study. European and dibetes. Diabetologia 2001;44(Suppl 3):B75–80.10.1007/PL00002958Search in Google Scholar

8. Sadauskaite-Kuehne V, Samuelsson U, Jasinskiene E, Padagia Z, Urbonaite B, et al. Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition. Diabetes Res Clin Pract 2002;55:247–54.10.1016/S0168-8227(01)00328-XSearch in Google Scholar

9. Akesen E, Turan S, Guran T, Atay Z, Save D, et al. Prevalence of type 1 diabetes mellitus in 6–18-yr-old school children living in Istanbul, Turkey. Pediatr Diabetes 2011;12: 567–71.10.1111/j.1399-5448.2010.00744.xSearch in Google Scholar PubMed

10. Hatun Ş. Diabetes program at schools in Turkey. J Clin Res Pediatr Endocrinol 2012;4:114–5.10.4274/Jcrpe.516Search in Google Scholar PubMed PubMed Central

11. Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Akın M, Çoban D, et al. Body weight, length and head circumference at birth in a cohort of Turkish newborns. J Clin Res Pediatr Endocrinol 2012;4:132–9.10.4274/Jcrpe.693Search in Google Scholar

12. Tanner JM. Recording adolescent physical changes. Tanner System Del Med J 1973;45:84–8.Search in Google Scholar

13. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, et al. Growth references for Turkish children aged 6–18 years. Acta Paediatr 2006;95:1635–41.10.1080/08035250600652013Search in Google Scholar PubMed

14. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, et al. Body mass index references for Turkish children. Acta Padiatr 2006;95:194–8.10.1080/08035250500334738Search in Google Scholar PubMed

15. The Diabetes Control and Complications Trial Research Group. Effect of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987;65:30–6.10.1210/jcem-65-1-30Search in Google Scholar PubMed

16. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1998;128:517–23.10.7326/0003-4819-128-7-199804010-00001Search in Google Scholar PubMed

17. Vanelli M, Chiari G, Costi G, Ghizzoni L, Giacalone T, et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. Diabetes Care 1999;22:7–9.10.2337/diacare.22.1.7Search in Google Scholar PubMed

18. Knip M, Reunanen A, Virtanen SM, Nuutinen M, Viikari J, et al. Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes? Pediatr Diabetes 2008;9:46–9.10.1111/j.1399-5448.2007.00344.xSearch in Google Scholar PubMed

19. Merger SR, Leslie RD, Boehm BO. The broad clinical phenotype of type 1 diabetes at presentation. Diabet Med 2013;30:170–8.10.1111/dme.12048Search in Google Scholar PubMed

20. Böber E, Dündar B, Büyükgebiz A. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2001;14:435–41.10.1515/JPEM.2001.14.4.435Search in Google Scholar

21. Komulainen J, Lounamaa R, Knip M, Kaprio EA, Akerblom HK. Ketoacidosis at diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child 1996;75:410–5.10.1136/adc.75.5.410Search in Google Scholar PubMed PubMed Central

22. Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Cheramy M, et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008;359:1909–20.10.1056/NEJMoa0804328Search in Google Scholar

23. Mortensen HB, Swift GF, Holl RW, Hougaard P, Hansen L, et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatric Diabetes 2010;11:218–26.10.1111/j.1399-5448.2009.00566.xSearch in Google Scholar

24. Al Alwan I, Bin Dajim N, Jawdat D, Tamimi W, Al Ahmdi R, et al. Prevalence of autoantibodies in children newly diagnosed with type 1 diabetes mellitus. Br J Biomed Sci 2012;69:31–3.10.1080/09674845.2012.11669919Search in Google Scholar

25. Lo FS, Yang MH, Chang LY, Ou YC, Van YH. Clinical features of type 1 diabetic children at initial diagnosis. Acta Paediatrica Taiwanica 2004;45:218–23.Search in Google Scholar

26. Szypowska A, Skorka A. The risk factors of ketoacidosis in children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes 2011;12:302–6.10.1111/j.1399-5448.2010.00689.xSearch in Google Scholar

27. Amos AF, McCarty DJ, Zimmer P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(Suppl 5):S1–85.10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.0.CO;2-RSearch in Google Scholar

28. Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ 2011;343:d4092.10.1136/bmj.d4092Search in Google Scholar

29. de Vries L, Oren L, Yebenthal Y, Shalitin S, Lazar L, et al. Decrease in frequency of ketoacidosis at diabetes onset over the past two decades – perspectives of a paediatric tertiary care centre. Diabet Med 2012;29:e170–5.10.1111/j.1464-5491.2012.03679.xSearch in Google Scholar

Received: 2013-2-12
Accepted: 2013-5-14
Published Online: 2013-06-08
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0060/html
Scroll to top button